DVAX

100.00% -15.50

Dopo l'orario di chiusura: 15.49 15.49 +

Dynavax Technologies Corp (DVAX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Dynavax Technologies Corp Stock (DVAX) Company Profile

Dynavax Technologies Corp

Healthcare (1106)

(510) 848-5100

2100 POWELL STREET, EMERYVILLE, CA

@DynavaxCorp

Prossima data di guadagno

Ultimi documenti SEC

DVAX's Discussions on Twitter

Compare DVAX vs TAK, ZTS, HLN, TEVA, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
DVAX Dynavax Technologies Corp	0.00	1.76B	260.81M	20.48M	22.67M	0.13
TAK Takeda Pharmaceutical Co Adr	18.22	57.12B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	125.96	53.16B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	10.47	47.25B	14.54B	2.22B	2.58B	0.4879
TEVA Teva Pharmaceutical Industries Ltd Adr	32.91	37.59B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	490.21	21.85B	3.13B	1.27B	1.12B	26.39

Dynavax Technologies Corp Stock (DVAX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-02-11	Downgrade	Goldman	Neutral → Sell
2024-02-01	Iniziato	Goldman	Neutral
2022-09-27	Iniziato	JMP Securities	Mkt Outperform
2022-01-06	Ripresa	Goldman	Buy
2021-08-06	Iniziato	Goldman	Buy
2020-08-07	Reiterato	H.C. Wainwright	Buy
2020-08-03	Reiterato	H.C. Wainwright	Buy
2020-06-15	Iniziato	Evercore ISI	Outperform
2019-10-18	Iniziato	H.C. Wainwright	Buy
2019-07-11	Aggiornamento	Cantor Fitzgerald	Neutral → Overweight
2019-02-27	Reiterato	Cantor Fitzgerald	Overweight
2018-05-10	Aggiornamento	JP Morgan	Neutral → Overweight
2018-03-08	Reiterato	Cantor Fitzgerald	Overweight
2018-02-14	Downgrade	JP Morgan	Overweight → Neutral
2017-09-25	Reiterato	RBC Capital Mkts	Outperform
2017-09-15	Iniziato	Cantor Fitzgerald	Overweight
2017-07-31	Aggiornamento	JP Morgan	Neutral → Overweight
2017-07-31	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2017-05-09	Reiterato	RBC Capital Mkts	Sector Perform
2016-04-28	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2016-04-27	Downgrade	JP Morgan	Overweight → Neutral
2015-11-30	Iniziato	RBC Capital Mkts	Outperform
2013-11-25	Aggiornamento	MLV & Co	Hold → Buy
2013-02-25	Downgrade	MLV & Co	Buy → Hold
2012-11-16	Reiterato	MLV & Co	Buy

Mostra tutto

Dynavax Technologies Corp Borsa (DVAX) Ultime notizie

Dynavax Technologies Corp Azioni (DVAX) Dati Finanziari

Dynavax Technologies Corp (DVAX)

Dynavax Technologies Corp Stock (DVAX) Company Profile

Compare DVAX vs TAK, ZTS, HLN, TEVA, UTHR

Dynavax Technologies Corp Stock (DVAX) Upgrades & Downgrades

Dynavax Technologies Corp Borsa (DVAX) Ultime notizie

USA Herald - USA Herald

DVAX Technical Analysis & ETF Price Forecast - Intellectia AI

[15-12G] DYNAVAX TECHNOLOGIES CORP SEC Filing - Stock Titan

M&A activity drives infectious disease stock rebound - BioWorld MedTech

Can Dynavax Technologies Corporation (DYF1) stock surprise with quarterly resultsJuly 2025 Opening Moves & Safe Capital Investment Plans - mfd.ru

Merger Talk: Does Mangoceuticals Inc have a sustainable dividendJuly 2025 Reactions & Expert Curated Trade Ideas - baoquankhu1.vn

Dynavax Technologies (DVAX) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Dynavax Technologies Leads Six-Month Stock Returns with 50.05% Gain - Markets Mojo

Sanofi Buyout Ends Dynavax Listing And Shifts Vaccine Upside To Group - Yahoo Finance

A Look At Dynavax Technologies (DVAX) Valuation As Pipeline Prospects Meet Conflicting Fair Value Estimates - Yahoo Finance

Is It Time To Reassess Dynavax (DVAX) After The Agreed Sanofi Cash Acquisition Deal - Yahoo Finance

Sanofi Concludes $2.2 Billion Takeover of Dynavax Technologies - marketscreener.com

Sanofi completes acquisition of Dynavax Technologies, triggers Nasdaq delisting - Investing.com

Dynavax Technologies Announces Board and Officer Changes Following Merger - TradingView

Sanofi closes Dynavax (NASDAQ: DVAX) takeover, delisting shares at $15.50 cash - Stock Titan

Press Release: Sanofi completes the acquisition of Dynavax - Yahoo Finance

Sanofi to merge Dynavax (NASDAQ: DVAX) after $15.50 per share cash tender - Stock Titan

Sanofi Completes Acquisition of Dynavax for $2.2 Billion - CHEManager

Profit Recap: What hedge funds are buying Primech Holdings LtdPortfolio Risk Report & Risk Controlled Swing Alerts - baoquankhu1.vn

Dynavax Technologies Corporation (NASDAQ:DVAX) Receives $24.33 Average Price Target from Analysts - Defense World

Trading Action: Is Dynavax Technologies Corporation forming a bullish divergenceWeekly Profit Report & Low Risk Entry Point Tips - baoquankhu1.vn

DVAX Should I Buy - Intellectia AI

Short Interest in Dynavax Technologies Corporation (NASDAQ:DVAX) Declines By 14.0% - MarketBeat

Assessing Dynavax Technologies (DVAX) Valuation After Recent Share Price Momentum And Ongoing Pipeline Investment - simplywall.st

AlphaQuest LLC Boosts Stock Position in Dynavax Technologies Corporation $DVAX - Defense World

Sanofi Buyout Of Dynavax Recasts Adult Vaccine Growth For Shareholders - simplywall.st

Dynavax President and COO Sells 114,000 Shares on Sanofi Acquisition News - AOL.com

Dynavax President and COO Sells 114,000 Shares on Sanofi Acquisition News - The Motley Fool

Sanofi (DVAX) tender offer wins antitrust clearance as shareholders sue - stocktitan.net

Sanofi tender offer progresses; Dynavax (NASDAQ: DVAX) discloses insider holdings and litigation - Stock Titan

Signal Recap: Does Dynavax Technologies Corporation stock have upside surprise potentialJuly 2025 Gainers & AI Driven Stock Movement Reports - baoquankhu1.vn

Dynavax president Novack sells $1.78m in shares - Investing.com

Dynavax CEO ignored last-minute suitor's email after signing $2.2 billion Sanofi deal - The Business Journals

Dynavax Technologies (NASDAQ:DVAX) Stock Passes Above 200 Day Moving AverageTime to Sell? - MarketBeat

Ocular Therapeutix Rejects Sanofi's Bid, Stock Surges 13% - Intellectia AI

Jim Cramer Highlights Sanofi's Bid for Dynavax - Finviz

Jim Cramer Highlights Sanofi’s Bid for Dynavax - Insider Monkey

Dynavax Technologies Corporation (DVAX) Investor Outlook: Exploring a 30.74% Potential Upside - DirectorsTalk Interviews

Dynavax Shares Surge as Acquisition Battle Looms - AD HOC NEWS

Dynavax (DVAX) Shares Rise 1.9% as New Bidder Emerges Post-Sanofi Deal - Intellectia AI

Dynavax Technologies (NASDAQ:DVAX) Sets New 12-Month HighStill a Buy? - MarketBeat

Dynavax gains on disclosure another bidder interested after deal announced (DVAX:NASDAQ) - Seeking Alpha

Dynavax Technologies stock hits 52-week high at $15.68 - Investing.com

Dynavax Technologies Corporation (NASDAQ:DVAX) Receives Average Rating of “Hold” from Brokerages - Defense World

Is It Time To Reassess Dynavax Technologies (DVAX) After Its Recent Share Price Surge - Yahoo Finance

Will Dynavax Technologies Corporation stock beat EPS estimatesJuly 2025 Outlook & Weekly High Return Opportunities - Улправда

Is Dynavax Technologies Corporation stock ready for breakoutWeekly Profit Recap & High Accuracy Buy Signal Tips - Улправда

How analysts rate Dynavax Technologies Corporation stock todayJuly 2025 Snapshot & Verified Swing Trading Watchlist - ulpravda.ru

Is Dynavax Technologies Corporation (DYF1) stock cheap vs fundamentalsWeekly Trade Analysis & Community Driven Trade Alerts - ulpravda.ru

What risks investors should watch in Dynavax Technologies Corporation stockJuly 2025 Chart Watch & High Accuracy Trade Alerts - Улправда

Dynavax Technologies CorporationCommon Stock (NQ: DVAX - FinancialContent

Dynavax Technologies Corp Azioni (DVAX) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a DVAX